minimal residual disease

C2i Genomics and Karkinos Healthcare Partner to Bring AI-Powered Cancer Detection

MUMBAI:C2i Genomics, a cancer intelligence company, today announced a strategic partnership with  Karkinos Healthcare , a technology led managed care…

2 years ago

This website uses cookies.